{"gene":"RUBCNL","run_date":"2026-06-10T07:46:28","timeline":{"discoveries":[{"year":2019,"finding":"RUBCNL/Pacer promotes autolysosome formation by engaging both the class III phosphatidylinositol 3-kinase (PtdIns3K) complex and the HOPS complex. Hepatocyte-specific rubcnl knockout in mice results in impaired autophagy flux, glycogen and lipid accumulation, and liver fibrosis.","method":"Hepatocyte-specific knockout mouse model, in vitro and in vivo autophagy flux assays","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout with multiple orthogonal phenotypic readouts (autophagy flux, lipid/glycogen accumulation, fibrosis), replicated across in vitro and in vivo systems","pmids":["30894088"],"is_preprint":false},{"year":2019,"finding":"Under nutrient-rich conditions, RUBCNL is inactivated by MTORC1-mediated phosphorylation. Upon nutrient deprivation, RUBCNL is dephosphorylated and subsequently acetylated by the activated GSK3-KAT5/TIP60 pathway; this acetylation significantly enhances HOPS complex recruitment, leading to more efficient autophagosome maturation.","method":"Phosphorylation/acetylation biochemical assays, kinase pathway manipulation (MTORC1, GSK3-KAT5/TIP60), in vitro and in vivo functional readouts","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — identified specific post-translational modifications (phosphorylation by MTORC1, acetylation by GSK3-KAT5), linked to functional outcome (HOPS recruitment, autophagosome maturation), validated both in vitro and in vivo","pmids":["30894088"],"is_preprint":false},{"year":2023,"finding":"Histone H3 lysine 18 lactylation (H3K18la), induced by tumor-derived lactate and hypoxia-driven glycolysis, promotes transcription of RUBCNL/Pacer. Upregulated RUBCNL then facilitates autophagosome maturation by interacting with BECN1 (beclin 1) and mediating recruitment and function of the class III phosphatidylinositol 3-kinase complex, contributing to hypoxic CRC cell survival and bevacizumab resistance.","method":"Histone lactylation assays, chromatin analysis, Co-IP (RUBCNL–BECN1 interaction), patient-derived organoid and xenograft models, loss-of-function experiments","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP for RUBCNL–BECN1 interaction, multiple orthogonal models (PDO, PDX), epigenetic mechanism linked to transcriptional upregulation of RUBCNL","pmids":["37615625"],"is_preprint":false},{"year":2024,"finding":"RUBCNL/PACER forms a complex with RIPK1 that disassembles in response to TNF. RUBCNL negatively regulates both RIPK1 kinase-dependent apoptosis and necroptosis in mesenchymal stem cells, and limits assembly of the RIPK1–TNFRSF1A/TNFR1 complex I. RUBCNL mutants that lose autophagy-regulatory function retain their cell death-suppressive function, indicating these are separable activities.","method":"Co-IP, proximity ligation assay (PLA), loss-of-function (siRNA) and gain-of-function, domain-separation mutant analysis, TNF-induced apoptosis/necroptosis assays","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and PLA for RUBCNL–RIPK1 complex, domain-separation mutants establishing separable functions, multiple cell death pathway readouts","pmids":["38873940"],"is_preprint":false},{"year":2024,"finding":"Constitutive neuronal overexpression of PACER/RUBCNL in the SOD1G93A ALS mouse model unexpectedly accelerated disease onset and shortened lifespan, and increased accumulation of SOD1 aggregates both in vivo and in vitro, suggesting that excess RUBCNL impairs autophagy rather than enhancing it, indicating that a precise balance of RUBCNL protein levels is required for proteostasis.","method":"Transgenic mouse model (neuron-specific PACER overexpression × SOD1G93A), in vitro neuronal overexpression, SOD1 aggregate quantification, disease-course monitoring","journal":"Biological research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic model with functional phenotype readouts, but gain-of-function result is unexpected and mechanistic explanation (how excess RUBCNL impairs autophagy) is not fully resolved","pmids":["39551782"],"is_preprint":false},{"year":2013,"finding":"Re-expression of C13ORF18/RUBCNL via artificial transcription factors in cervical cancer cell lines (where the gene is hypermethylated and silenced) caused significant cell growth inhibition and/or induction of apoptosis, establishing a tumor suppressor function. Re-activation also led to partial demethylation of the C13ORF18 promoter and decreased repressive histone methylation.","method":"Artificial transcription factor (zinc finger protein fused to transcriptional activator)-mediated re-expression, cell proliferation assays, apoptosis assays, bisulfite methylation analysis, histone methylation analysis","journal":"Molecular oncology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — gene-specific re-expression with defined functional phenotype (growth inhibition, apoptosis), multiple cell lines, but molecular mechanism downstream of RUBCNL re-expression is not characterized","pmids":["23522960"],"is_preprint":false},{"year":2023,"finding":"Syk regulates neutrophil immune responses via the mTOR/RUBCNL-dependent autophagy pathway; pharmacological Syk inhibition modulates RUBCNL-dependent autophagy to suppress pro-inflammatory neutrophil functions in ulcerative colitis.","method":"RNA sequencing, pharmacological inhibition (R788/Syk inhibitor), qRT-PCR, Western blot, DSS-induced murine colitis model","journal":"Precision clinical medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pathway placement of RUBCNL downstream of mTOR/Syk is inferred from pharmacological inhibition and gene expression, without direct mechanistic dissection of RUBCNL's role","pmids":["37941642"],"is_preprint":false}],"current_model":"RUBCNL/Pacer is a vertebrate-specific autophagy enhancer that promotes autophagosome maturation by interacting with BECN1 and recruiting both the class III PtdIns3K and HOPS complexes; its activity is controlled by a nutrient-sensitive post-translational modification switch (MTORC1-mediated inactivating phosphorylation under nutrient-rich conditions, and GSK3-KAT5/TIP60-mediated activating acetylation upon starvation that boosts HOPS recruitment); it also forms a complex with RIPK1 to suppress TNF-induced RIPK1-dependent apoptosis and necroptosis independently of its autophagy function, and its expression is epigenetically regulated by histone lactylation in hypoxic tumor cells."},"narrative":{"mechanistic_narrative":"RUBCNL (Pacer/C13ORF18) is an autophagy enhancer that promotes the maturation of autophagosomes into autolysosomes by engaging both the class III phosphatidylinositol 3-kinase (PtdIns3K) complex and the HOPS complex, with hepatocyte-specific loss in mice causing impaired autophagy flux, glycogen and lipid accumulation, and liver fibrosis [PMID:30894088]. It executes this function through direct interaction with BECN1, mediating recruitment and activity of the class III PtdIns3K complex [PMID:37615625]. RUBCNL activity is gated by a nutrient-sensitive modification switch: MTORC1-mediated phosphorylation inactivates it under nutrient-rich conditions, while starvation triggers dephosphorylation and GSK3-KAT5/TIP60-mediated acetylation that enhances HOPS recruitment and accelerates maturation [PMID:30894088]. Beyond autophagy, RUBCNL forms a complex with RIPK1 that disassembles upon TNF stimulation, and through this interaction it limits assembly of the RIPK1-TNFR1 complex I and suppresses RIPK1 kinase-dependent apoptosis and necroptosis; mutants lacking autophagy-regulatory function retain this cell-death-suppressive activity, establishing the two roles as separable [PMID:38873940]. RUBCNL expression is epigenetically controlled, being transcriptionally driven by histone H3K18 lactylation in hypoxic tumor cells [PMID:37615625] and silenced by promoter hypermethylation in cervical cancer, where its re-expression inhibits growth and induces apoptosis [PMID:23522960].","teleology":[{"year":2013,"claim":"Before its autophagy role was known, RUBCNL (then C13ORF18) was characterized as an epigenetically silenced gene whose re-expression has tumor-suppressive consequences, establishing the first functional link to cell growth control.","evidence":"Artificial transcription factor-mediated re-expression in hypermethylated cervical cancer lines with proliferation and apoptosis assays and methylation analysis","pmids":["23522960"],"confidence":"Medium","gaps":["molecular mechanism downstream of re-expression not characterized","no connection drawn to autophagy at this stage","tumor-suppressor role tested only in cervical cancer cell lines"]},{"year":2019,"claim":"Established RUBCNL/Pacer as an autophagy maturation factor by showing it engages both the class III PtdIns3K and HOPS complexes to drive autolysosome formation, with in vivo loss causing metabolic and fibrotic liver pathology.","evidence":"Hepatocyte-specific knockout mice plus in vitro/in vivo autophagy flux assays","pmids":["30894088"],"confidence":"High","gaps":["structural basis of dual PtdIns3K/HOPS engagement not resolved","interaction interfaces not mapped"]},{"year":2019,"claim":"Defined how RUBCNL activity is tied to nutrient status, identifying an inactivating MTORC1 phosphorylation and a starvation-induced GSK3-KAT5/TIP60 acetylation that boosts HOPS recruitment.","evidence":"Phospho/acetylation biochemistry with kinase-pathway manipulation and functional autophagy readouts","pmids":["30894088"],"confidence":"High","gaps":["specific modified residues and their stoichiometry under physiological conditions not fully detailed","phosphatase mediating dephosphorylation not identified"]},{"year":2023,"claim":"Connected RUBCNL to disease-relevant transcriptional control by showing tumor lactate-driven H3K18 lactylation upregulates RUBCNL, which then promotes BECN1-dependent autophagosome maturation to support hypoxic tumor survival and drug resistance.","evidence":"Histone lactylation/chromatin assays, reciprocal Co-IP for RUBCNL-BECN1, patient-derived organoid and xenograft models, loss-of-function","pmids":["37615625"],"confidence":"High","gaps":["whether lactylation regulates RUBCNL in non-tumor settings unknown","direct binding interface with BECN1 not mapped"]},{"year":2024,"claim":"Revealed an autophagy-independent function: RUBCNL complexes with RIPK1 to restrain TNF-induced apoptosis and necroptosis, with domain-separation mutants proving the cell-death and autophagy roles are genetically separable.","evidence":"Co-IP, proximity ligation assay, siRNA loss-of-function and gain-of-function, domain-separation mutants, TNF-induced death assays in mesenchymal stem cells","pmids":["38873940"],"confidence":"High","gaps":["structural basis for RIPK1 complex assembly/disassembly not defined","whether this role generalizes beyond mesenchymal stem cells untested"]},{"year":2024,"claim":"Tested the assumption that more RUBCNL means more autophagy and found the opposite in neurons, where overexpression worsened ALS pathology and SOD1 aggregation, indicating proteostasis requires balanced RUBCNL levels.","evidence":"Neuron-specific PACER overexpression crossed with SOD1G93A mice, in vitro neuronal overexpression, aggregate quantification, disease-course monitoring","pmids":["39551782"],"confidence":"Medium","gaps":["mechanism by which excess RUBCNL impairs autophagy unresolved","unexpected gain-of-function result not independently confirmed","relevance to non-SOD1 neurodegeneration unknown"]},{"year":2023,"claim":"Placed RUBCNL downstream of Syk/mTOR signaling in regulating inflammatory neutrophil autophagy in colitis, extending its pathway context to immune regulation.","evidence":"RNA-seq, Syk pharmacological inhibition, qRT-PCR/Western blot, DSS-induced murine colitis model","pmids":["37941642"],"confidence":"Low","gaps":["pathway placement inferred from pharmacology and expression without direct mechanistic dissection of RUBCNL's role","no demonstration that RUBCNL itself is the effector of Syk inhibition"]},{"year":null,"claim":"How the dual PtdIns3K/HOPS engagement, the nutrient-sensitive modification switch, and the RIPK1-binding cell-death function are structurally organized within RUBCNL, and how RUBCNL dosage produces opposing autophagy outcomes, remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["no structural model of RUBCNL or its complexes","no resolution of how excess protein impairs rather than enhances autophagy","binding interfaces with BECN1, HOPS, and RIPK1 not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3]}],"localization":[],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[3]}],"complexes":["RIPK1 complex","class III PtdIns3K complex","HOPS complex"],"partners":["BECN1","RIPK1","TNFRSF1A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H714","full_name":"Protein associated with UVRAG as autophagy enhancer","aliases":["Protein Rubicon-like"],"length_aa":662,"mass_kda":73.5,"function":"Regulator of autophagy that promotes autophagosome maturation by facilitating the biogenesis of phosphatidylinositol 3-phosphate (PtdIns(3)P) in late steps of autophagy (PubMed:28306502, PubMed:30704899). Acts by antagonizing RUBCN, thereby stimulating phosphatidylinositol 3-kinase activity of the PI3K/PI3KC3 complex (PubMed:28306502). Following anchorage to the autophagosomal SNARE STX17, promotes the recruitment of PI3K/PI3KC3 and HOPS complexes to the autophagosome to regulate the fusion specificity of autophagosomes with late endosomes/lysosomes (PubMed:28306502). Binds phosphoinositides phosphatidylinositol 3-phosphate (PtdIns(3)P), 4-phosphate (PtdIns(4)P) and 5-phosphate (PtdIns(5)P) (PubMed:28306502). In addition to its role in autophagy, acts as a regulator of lipid and glycogen homeostasis (By similarity). May act as a tumor suppressor (Probable)","subcellular_location":"Cytoplasmic vesicle, autophagosome membrane","url":"https://www.uniprot.org/uniprotkb/Q9H714/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RUBCNL","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"UVRAG","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/RUBCNL","total_profiled":1310},"omim":[{"mim_id":"620175","title":"RUBICON-LIKE AUTOPHAGY ENHANCER; RUBCNL","url":"https://www.omim.org/entry/620175"},{"mim_id":"613516","title":"RUN DOMAIN- AND CYSTEINE-RICH DOMAIN-CONTAINING BECLIN-1-INTERACTING PROTEIN; RUBCN","url":"https://www.omim.org/entry/613516"},{"mim_id":"604204","title":"SYNTAXIN 17; STX17","url":"https://www.omim.org/entry/604204"},{"mim_id":"179509","title":"RAS-ASSOCIATED PROTEIN RAB2; RAB2","url":"https://www.omim.org/entry/179509"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":38.5}],"url":"https://www.proteinatlas.org/search/RUBCNL"},"hgnc":{"alias_symbol":["FLJ21562","PACER"],"prev_symbol":["C13orf18","KIAA0226L"]},"alphafold":{"accession":"Q9H714","domains":[{"cath_id":"3.30.40.10","chopping":"424-498","consensus_level":"high","plddt":94.3804,"start":424,"end":498},{"cath_id":"-","chopping":"603-662","consensus_level":"medium","plddt":89.9095,"start":603,"end":662},{"cath_id":"1.20.1270","chopping":"502-601","consensus_level":"medium","plddt":93.526,"start":502,"end":601}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H714","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H714-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H714-F1-predicted_aligned_error_v6.png","plddt_mean":60.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RUBCNL","jax_strain_url":"https://www.jax.org/strain/search?query=RUBCNL"},"sequence":{"accession":"Q9H714","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H714.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H714/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H714"}},"corpus_meta":[{"pmid":"37615625","id":"PMC_37615625","title":"Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.","date":"2023","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/37615625","citation_count":364,"is_preprint":false},{"pmid":"19843677","id":"PMC_19843677","title":"Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings.","date":"2009","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19843677","citation_count":56,"is_preprint":false},{"pmid":"23522960","id":"PMC_23522960","title":"Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors.","date":"2013","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23522960","citation_count":37,"is_preprint":false},{"pmid":"30894088","id":"PMC_30894088","title":"RUBCNL/Pacer and RUBCN/Rubicon in regulation of autolysosome formation and lipid metabolism.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30894088","citation_count":22,"is_preprint":false},{"pmid":"38873940","id":"PMC_38873940","title":"The autophagy protein RUBCNL/PACER represses RIPK1 kinase-dependent apoptosis and necroptosis.","date":"2024","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/38873940","citation_count":18,"is_preprint":false},{"pmid":"25169519","id":"PMC_25169519","title":"C13orf18 and C1orf166 (MULAN) DNA genes methylation are not associated with cervical cancer and precancerous lesions of human papillomavirus genotypes in Iranian women.","date":"2014","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/25169519","citation_count":13,"is_preprint":false},{"pmid":"37941642","id":"PMC_37941642","title":"Blockade of Syk modulates neutrophil immune-responses via the mTOR/RUBCNL-dependent autophagy pathway to alleviate intestinal inflammation in ulcerative colitis.","date":"2023","source":"Precision clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37941642","citation_count":13,"is_preprint":false},{"pmid":"37130182","id":"PMC_37130182","title":"MYC-activated CERS6-AS1 sponges miR-6838-5p and regulates the expression of RUBCNL in colorectal cancer.","date":"2022","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/37130182","citation_count":5,"is_preprint":false},{"pmid":"29664054","id":"PMC_29664054","title":"Limited Role of Promoter Methylation of MGMT and C13ORF18 in Triage of Low-Grade Squamous Intraepithelial Lesion.","date":"2018","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/29664054","citation_count":5,"is_preprint":false},{"pmid":"39551782","id":"PMC_39551782","title":"Overexpression of autophagy enhancer PACER/RUBCNL in neurons accelerates disease in the SOD1G93A ALS mouse model.","date":"2024","source":"Biological research","url":"https://pubmed.ncbi.nlm.nih.gov/39551782","citation_count":4,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8367,"output_tokens":2129,"usd":0.028518,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9126,"output_tokens":3014,"usd":0.06049,"stage2_stop_reason":"end_turn"},"total_usd":0.089008,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"RUBCNL/Pacer promotes autolysosome formation by engaging both the class III phosphatidylinositol 3-kinase (PtdIns3K) complex and the HOPS complex. Hepatocyte-specific rubcnl knockout in mice results in impaired autophagy flux, glycogen and lipid accumulation, and liver fibrosis.\",\n      \"method\": \"Hepatocyte-specific knockout mouse model, in vitro and in vivo autophagy flux assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout with multiple orthogonal phenotypic readouts (autophagy flux, lipid/glycogen accumulation, fibrosis), replicated across in vitro and in vivo systems\",\n      \"pmids\": [\"30894088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Under nutrient-rich conditions, RUBCNL is inactivated by MTORC1-mediated phosphorylation. Upon nutrient deprivation, RUBCNL is dephosphorylated and subsequently acetylated by the activated GSK3-KAT5/TIP60 pathway; this acetylation significantly enhances HOPS complex recruitment, leading to more efficient autophagosome maturation.\",\n      \"method\": \"Phosphorylation/acetylation biochemical assays, kinase pathway manipulation (MTORC1, GSK3-KAT5/TIP60), in vitro and in vivo functional readouts\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — identified specific post-translational modifications (phosphorylation by MTORC1, acetylation by GSK3-KAT5), linked to functional outcome (HOPS recruitment, autophagosome maturation), validated both in vitro and in vivo\",\n      \"pmids\": [\"30894088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Histone H3 lysine 18 lactylation (H3K18la), induced by tumor-derived lactate and hypoxia-driven glycolysis, promotes transcription of RUBCNL/Pacer. Upregulated RUBCNL then facilitates autophagosome maturation by interacting with BECN1 (beclin 1) and mediating recruitment and function of the class III phosphatidylinositol 3-kinase complex, contributing to hypoxic CRC cell survival and bevacizumab resistance.\",\n      \"method\": \"Histone lactylation assays, chromatin analysis, Co-IP (RUBCNL–BECN1 interaction), patient-derived organoid and xenograft models, loss-of-function experiments\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP for RUBCNL–BECN1 interaction, multiple orthogonal models (PDO, PDX), epigenetic mechanism linked to transcriptional upregulation of RUBCNL\",\n      \"pmids\": [\"37615625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RUBCNL/PACER forms a complex with RIPK1 that disassembles in response to TNF. RUBCNL negatively regulates both RIPK1 kinase-dependent apoptosis and necroptosis in mesenchymal stem cells, and limits assembly of the RIPK1–TNFRSF1A/TNFR1 complex I. RUBCNL mutants that lose autophagy-regulatory function retain their cell death-suppressive function, indicating these are separable activities.\",\n      \"method\": \"Co-IP, proximity ligation assay (PLA), loss-of-function (siRNA) and gain-of-function, domain-separation mutant analysis, TNF-induced apoptosis/necroptosis assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and PLA for RUBCNL–RIPK1 complex, domain-separation mutants establishing separable functions, multiple cell death pathway readouts\",\n      \"pmids\": [\"38873940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Constitutive neuronal overexpression of PACER/RUBCNL in the SOD1G93A ALS mouse model unexpectedly accelerated disease onset and shortened lifespan, and increased accumulation of SOD1 aggregates both in vivo and in vitro, suggesting that excess RUBCNL impairs autophagy rather than enhancing it, indicating that a precise balance of RUBCNL protein levels is required for proteostasis.\",\n      \"method\": \"Transgenic mouse model (neuron-specific PACER overexpression × SOD1G93A), in vitro neuronal overexpression, SOD1 aggregate quantification, disease-course monitoring\",\n      \"journal\": \"Biological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic model with functional phenotype readouts, but gain-of-function result is unexpected and mechanistic explanation (how excess RUBCNL impairs autophagy) is not fully resolved\",\n      \"pmids\": [\"39551782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Re-expression of C13ORF18/RUBCNL via artificial transcription factors in cervical cancer cell lines (where the gene is hypermethylated and silenced) caused significant cell growth inhibition and/or induction of apoptosis, establishing a tumor suppressor function. Re-activation also led to partial demethylation of the C13ORF18 promoter and decreased repressive histone methylation.\",\n      \"method\": \"Artificial transcription factor (zinc finger protein fused to transcriptional activator)-mediated re-expression, cell proliferation assays, apoptosis assays, bisulfite methylation analysis, histone methylation analysis\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — gene-specific re-expression with defined functional phenotype (growth inhibition, apoptosis), multiple cell lines, but molecular mechanism downstream of RUBCNL re-expression is not characterized\",\n      \"pmids\": [\"23522960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Syk regulates neutrophil immune responses via the mTOR/RUBCNL-dependent autophagy pathway; pharmacological Syk inhibition modulates RUBCNL-dependent autophagy to suppress pro-inflammatory neutrophil functions in ulcerative colitis.\",\n      \"method\": \"RNA sequencing, pharmacological inhibition (R788/Syk inhibitor), qRT-PCR, Western blot, DSS-induced murine colitis model\",\n      \"journal\": \"Precision clinical medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pathway placement of RUBCNL downstream of mTOR/Syk is inferred from pharmacological inhibition and gene expression, without direct mechanistic dissection of RUBCNL's role\",\n      \"pmids\": [\"37941642\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RUBCNL/Pacer is a vertebrate-specific autophagy enhancer that promotes autophagosome maturation by interacting with BECN1 and recruiting both the class III PtdIns3K and HOPS complexes; its activity is controlled by a nutrient-sensitive post-translational modification switch (MTORC1-mediated inactivating phosphorylation under nutrient-rich conditions, and GSK3-KAT5/TIP60-mediated activating acetylation upon starvation that boosts HOPS recruitment); it also forms a complex with RIPK1 to suppress TNF-induced RIPK1-dependent apoptosis and necroptosis independently of its autophagy function, and its expression is epigenetically regulated by histone lactylation in hypoxic tumor cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RUBCNL (Pacer/C13ORF18) is an autophagy enhancer that promotes the maturation of autophagosomes into autolysosomes by engaging both the class III phosphatidylinositol 3-kinase (PtdIns3K) complex and the HOPS complex, with hepatocyte-specific loss in mice causing impaired autophagy flux, glycogen and lipid accumulation, and liver fibrosis [#0]. It executes this function through direct interaction with BECN1, mediating recruitment and activity of the class III PtdIns3K complex [#2]. RUBCNL activity is gated by a nutrient-sensitive modification switch: MTORC1-mediated phosphorylation inactivates it under nutrient-rich conditions, while starvation triggers dephosphorylation and GSK3-KAT5/TIP60-mediated acetylation that enhances HOPS recruitment and accelerates maturation [#1]. Beyond autophagy, RUBCNL forms a complex with RIPK1 that disassembles upon TNF stimulation, and through this interaction it limits assembly of the RIPK1-TNFR1 complex I and suppresses RIPK1 kinase-dependent apoptosis and necroptosis; mutants lacking autophagy-regulatory function retain this cell-death-suppressive activity, establishing the two roles as separable [#3]. RUBCNL expression is epigenetically controlled, being transcriptionally driven by histone H3K18 lactylation in hypoxic tumor cells [#2] and silenced by promoter hypermethylation in cervical cancer, where its re-expression inhibits growth and induces apoptosis [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Before its autophagy role was known, RUBCNL (then C13ORF18) was characterized as an epigenetically silenced gene whose re-expression has tumor-suppressive consequences, establishing the first functional link to cell growth control.\",\n      \"evidence\": \"Artificial transcription factor-mediated re-expression in hypermethylated cervical cancer lines with proliferation and apoptosis assays and methylation analysis\",\n      \"pmids\": [\"23522960\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"molecular mechanism downstream of re-expression not characterized\",\n        \"no connection drawn to autophagy at this stage\",\n        \"tumor-suppressor role tested only in cervical cancer cell lines\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established RUBCNL/Pacer as an autophagy maturation factor by showing it engages both the class III PtdIns3K and HOPS complexes to drive autolysosome formation, with in vivo loss causing metabolic and fibrotic liver pathology.\",\n      \"evidence\": \"Hepatocyte-specific knockout mice plus in vitro/in vivo autophagy flux assays\",\n      \"pmids\": [\"30894088\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"structural basis of dual PtdIns3K/HOPS engagement not resolved\",\n        \"interaction interfaces not mapped\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined how RUBCNL activity is tied to nutrient status, identifying an inactivating MTORC1 phosphorylation and a starvation-induced GSK3-KAT5/TIP60 acetylation that boosts HOPS recruitment.\",\n      \"evidence\": \"Phospho/acetylation biochemistry with kinase-pathway manipulation and functional autophagy readouts\",\n      \"pmids\": [\"30894088\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"specific modified residues and their stoichiometry under physiological conditions not fully detailed\",\n        \"phosphatase mediating dephosphorylation not identified\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected RUBCNL to disease-relevant transcriptional control by showing tumor lactate-driven H3K18 lactylation upregulates RUBCNL, which then promotes BECN1-dependent autophagosome maturation to support hypoxic tumor survival and drug resistance.\",\n      \"evidence\": \"Histone lactylation/chromatin assays, reciprocal Co-IP for RUBCNL-BECN1, patient-derived organoid and xenograft models, loss-of-function\",\n      \"pmids\": [\"37615625\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"whether lactylation regulates RUBCNL in non-tumor settings unknown\",\n        \"direct binding interface with BECN1 not mapped\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed an autophagy-independent function: RUBCNL complexes with RIPK1 to restrain TNF-induced apoptosis and necroptosis, with domain-separation mutants proving the cell-death and autophagy roles are genetically separable.\",\n      \"evidence\": \"Co-IP, proximity ligation assay, siRNA loss-of-function and gain-of-function, domain-separation mutants, TNF-induced death assays in mesenchymal stem cells\",\n      \"pmids\": [\"38873940\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"structural basis for RIPK1 complex assembly/disassembly not defined\",\n        \"whether this role generalizes beyond mesenchymal stem cells untested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Tested the assumption that more RUBCNL means more autophagy and found the opposite in neurons, where overexpression worsened ALS pathology and SOD1 aggregation, indicating proteostasis requires balanced RUBCNL levels.\",\n      \"evidence\": \"Neuron-specific PACER overexpression crossed with SOD1G93A mice, in vitro neuronal overexpression, aggregate quantification, disease-course monitoring\",\n      \"pmids\": [\"39551782\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"mechanism by which excess RUBCNL impairs autophagy unresolved\",\n        \"unexpected gain-of-function result not independently confirmed\",\n        \"relevance to non-SOD1 neurodegeneration unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Placed RUBCNL downstream of Syk/mTOR signaling in regulating inflammatory neutrophil autophagy in colitis, extending its pathway context to immune regulation.\",\n      \"evidence\": \"RNA-seq, Syk pharmacological inhibition, qRT-PCR/Western blot, DSS-induced murine colitis model\",\n      \"pmids\": [\"37941642\"],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"pathway placement inferred from pharmacology and expression without direct mechanistic dissection of RUBCNL's role\",\n        \"no demonstration that RUBCNL itself is the effector of Syk inhibition\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the dual PtdIns3K/HOPS engagement, the nutrient-sensitive modification switch, and the RIPK1-binding cell-death function are structurally organized within RUBCNL, and how RUBCNL dosage produces opposing autophagy outcomes, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\n        \"no structural model of RUBCNL or its complexes\",\n        \"no resolution of how excess protein impairs rather than enhances autophagy\",\n        \"binding interfaces with BECN1, HOPS, and RIPK1 not mapped\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [\"RIPK1 complex\", \"class III PtdIns3K complex\", \"HOPS complex\"],\n    \"partners\": [\"BECN1\", \"RIPK1\", \"TNFRSF1A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":5,"faith_pct":80.0}}